title: [Rivaroxaban versus warfarin: results of the ROCKET study].
authors.forename: Judit
authors.initials: J
authors.lastname: Lipták
mesh_terms: D000925:Anticoagulants / Q000008:administration & dosage* / Q000009:adverse effects; D001281:Atrial Fibrillation / Q000150:complications* / Q000209:etiology; D002545:Brain Ischemia / Q000150:complications* / Q000209:etiology; D004311:Double-Blind Method; D006801:Humans; D009025:Morpholines / Q000008:administration & dosage* / Q000009:adverse effects; D015337:Multicenter Studies as Topic; D016032:Randomized Controlled Trials as Topic; D051437:Renal Insufficiency / Q000150:complications; D000069552:Rivaroxaban; D055502:Secondary Prevention / Q000379:methods; D012720:Severity of Illness Index; D020521:Stroke / Q000209:etiology / Q000517:prevention & control*; D013876:Thiophenes / Q000008:administration & dosage* / Q000009:adverse effects; D016896:Treatment Outcome; D014859:Warfarin / Q000008:administration & dosage* / Q000009:adverse effects
chemical_list: D000925:Anticoagulants; D009025:Morpholines; D013876:Thiophenes; D014859:Warfarin; D000069552:Rivaroxaban